Therapy News and Research

RSS

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.

9 Nov 2016

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

A large national study has confirmed the value of high-intensity statin treatments for people with cardiovascular disease, according to researchers at the Stanford University School of Medicine.

9 Nov 2016

Novel sensor can quantify effects of radiation on individual cancer cells

A team of Norwegian, French and Australian researchers is the first in the world to succeed in quantifying the effects of radiation on individual cancer cells.

9 Nov 2016

Using urine samples to diagnose disease in preterm newborns

The majority of patients in neonatal intensive care units are premature babies, who often have infectious (congenital pneumonia) or noninfectious (tachypnea, infant respiratory distress syndrome) respiratory pathologies.

9 Nov 2016

Scientists find new way to bypass bowel cancer's defence against treatment

BLOCKING a molecule could bypass bowel cancer's defence against the drug cetuximab, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.

9 Nov 2016

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy - a new approach to treating cancer by boosting a patient's immune system -- may fail in a substantial number of patients.

8 Nov 2016

UTHealth study receives $1.9 million NIH grant to identify effective treatment for cocaine addiction

Identifying more effective treatment strategies tailored to individual responses for patients overcoming addiction to cocaine is the focus of a new clinical trial at McGovern Medical School at The University of Texas Health Science Center at Houston.

8 Nov 2016

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs.

8 Nov 2016

Tailored dose-dense chemotherapy does not improve breast cancer recurrence-free survival

Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free survival, and nonhematologic toxic effects were more frequent in the tailored dose-dense group, according to a study appearing in the November 8 issue of JAMA.

8 Nov 2016

ASH partners with other organizations to address knowledge gaps in AML care

The American Society of Hematology has partnered with several organizations on independent educational programming designed to help address knowledge gaps in the diagnosis and treatment of acute myeloid leukemia (AML).

8 Nov 2016

Caltech researchers develop new technique that increases safety of TCR gene therapy

The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.

8 Nov 2016

Research reveals new molecular mechanisms of Huntington's disease

The research just published by a group of scientists from the Centre for Genomic Regulation (CRG) in Barcelona, Spain, led by Eulàlia Martí, in cooperation with researchers from the University of Barcelona (UB) and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), has brought to light new information on the molecular mechanisms that cause Huntington’s disease, and defines new pathways to therapy discovery.

8 Nov 2016

Single gene therapy for lipoprotein lipase deficiency reduces severity and frequency of pancreatitis

Over a 6-year period, patients with the genetic disease lipoprotein lipase deficiency (LPLD) who received a single gene therapy treatment of alipogene tiparvovec had a marked reduction in the severity and frequency of pancreatitis.

8 Nov 2016

Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

An international research team led by St. Jude Children's Research Hospital investigators has uncovered details of a new, high-risk subtype of acute lymphoblastic leukemia (ALL) as well as a possible targeted therapy.

8 Nov 2016

Second opinions may not reduce overtreatment in prostate cancer, study suggests

A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.

8 Nov 2016

Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

The links between Type 2 diabetes and cancer are complex: people suffering from diabetes mellitus essentially have a higher risk of developing cancer but, on top of that, some diabetes drugs are also suspected of increasing the risk in some cases.

8 Nov 2016

PENTAX Medical showcases latest innovations in endoscopy at UEGW 2016

PENTAX Medical highlighted “Quality in Focus: New Technologies Pushing Boundaries” at UEGW 2016, displaying its very latest endoscopic technology designed to support the clinical pathway through enhanced diagnosis and treatment.

8 Nov 2016

Study finds lack of improvement in health status of childhood cancer survivors

Long-term survivors of childhood cancer live longer thanks to improvements to cancer treatments, but a new study looking at three decades of therapy suggests patients do not report better health status.

8 Nov 2016

Scientists develop new computer-based method to assess cell communication networks

A multi-institution academic-industrial partnership of researchers led by Case Western Reserve University School of Medicine has developed a new method to broadly assess cell communication networks and identify disease-specific network anomalies.

8 Nov 2016

Biologic drugs may help prevent progressive bone loss in patients with RA

A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.

7 Nov 2016

Therapy News and Research

Investigational treatment combination improves virologic control in SIV-infected monkeys

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

Novel sensor can quantify effects of radiation on individual cancer cells

Using urine samples to diagnose disease in preterm newborns

Scientists find new way to bypass bowel cancer's defence against treatment

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

UTHealth study receives $1.9 million NIH grant to identify effective treatment for cocaine addiction

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

Tailored dose-dense chemotherapy does not improve breast cancer recurrence-free survival

ASH partners with other organizations to address knowledge gaps in AML care

Caltech researchers develop new technique that increases safety of TCR gene therapy

Research reveals new molecular mechanisms of Huntington's disease

Single gene therapy for lipoprotein lipase deficiency reduces severity and frequency of pancreatitis

Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

Second opinions may not reduce overtreatment in prostate cancer, study suggests

Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

PENTAX Medical showcases latest innovations in endoscopy at UEGW 2016

Study finds lack of improvement in health status of childhood cancer survivors

Scientists develop new computer-based method to assess cell communication networks

Biologic drugs may help prevent progressive bone loss in patients with RA

Industry Focus eBook - Cell biology (5th edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News